Characterizing Intake & Eating Behaviors Among Individuals Prescribed GLP-1 Medications

Understanding Diet on GLP-1

At IAFNS, we advance nutrition science through rigorous research, collaboration, and evidence-based guidance.

GLP-1 Medications and Eating Behaviors

Medications which leverage the potent anorexigenic effects of the incretin hormone glucagon-like peptide-1 (GLP-1) represent a highly promising treatment modality for obesity. However, little is known about the eating behaviors or nutrient needs of free-living individuals taking these medications.

Purpose of the Study

The purpose of this observational study is to characterize the eating behaviors and preferences of these individuals to help inform dietary counseling and future approaches to meeting the specific dietary needs of this population.

What Investigators Will Measure

  • Changes in free-living dietary patterns
  • Types and amounts of foods and beverages consumed
  • Differences in eating behaviors prior to and during GLP-1 treatment
  • Liking and preference for different foods and tastes
  • Other dimensions of eating behaviors in response to treatment

The IAFNS Low- and No-Calorie Sweeteners Committee seeks to develop and communicate the science related to how the consumption of LNCSs can contribute to overall health and wellness. This includes the role of LNCSs in taste perception and food choices. See recent publications and upcoming events to learn more about the committee’s work.

This project is jointly supported by IAFNS Sodium in Food & Health Implications Committee which promotes a science-based approach to research on sodium in foods and food patterns to advance public health. See recent publications and upcoming events to learn more about the committee’s work.

Join Us >

Project Investigators

Faris Zuraikat, PhD
Columbia University

Barbara J. Rolls, PhD
Penn State University

Sarah Schmitz, MD
Weill Cornell Medicine

Alissa Smethers, PhD, RDN
Temple University

Marie-Pierre St-Onge, PhD
Columbia University

Ciaran Forde, PhD
Wageningen University, NL

Graham Finlayson, PhD
University of Leeds

Open Science

Aligned with IAFNS’ commitment to open science practices, this project has been added to the IAFNS Collection on the Open Science Framework. Note: this link redirects you to an external website.

Other Projects Supported by the Committee

Characterizing Intake & Eating Behaviors Among Individuals Prescribed GLP-1 Medications

Understanding Diet on GLP-1 At IAFNS, we advance nutrition science through rigorous research, collaboration, and evidence-based guidance. GLP-1 Medications and Eating Behaviors Medications which leverage […]

Sodium, Potassium & Blood Pressure: Evidence Map and Systematic Review

Balancing Sodium and Potassium At IAFNS, we advance food safety through rigorous research, collaboration, and science-based guidance. Sodium, Potassium, and Cardiovascular Health It is proposed […]

Validating Dual Column Food Products in Database

Open Data for Nutrition At IAFNS, we advance food safety through rigorous research, collaboration, and science-based guidance. USDA Global Branded Food Products Database The USDA […]